Institutional members access full text with Ovid®

Share this article on:

Deus ex Makena?

Das, Anita F. PhD; Birch, Robert PhD; Meis, Paul J. MD

doi: 10.1097/AOG.0b013e31822f8774
Departments: Letters to the Editor

Axistat Inc., San Francisco, California (Das)

KV Pharmaceutical Co., Bridgeton, Missouri (Birch)

Wake Forest University, Winston Salem, North Carolina (Meis)

Financial Disclosure: Dr. Birch is an employee of KV Pharmaceutical Co. Dr. Das is President of Axistat Inc., which is a contractor to KV Pharmaceutical Co. for statistical services for an ongoing trial of 17α-hydroxyprogesterone caproate. Dr. Meis is an advisor to KV Pharmaceutical Co. for an ongoing trial of 17α-hydroxyprogesterone caproate.

© 2011 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.